525
person
Li Gan, PhD
Li Gan, PhD, is director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at
Weill Cornell Medicine, where she is also the Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases.
+ Read More
person
Erik Roberson, MD, PhD
Erik Roberson, MD, PhD, is a physician-scientist with a focus on age-related neurodegenerative di
seases.
+ Read More
person
Bruce Miller, MD
Bruce Miller, MD, holds the A.W.
person
Stephen J. Haggarty, PhD
Stephen J.
person
David Siemer
David Siemer is the Co-Founder and CEO of Wave Digital Assets as well as the founder of Wavemaker
Partners and Wavemaker Genesis. Wavemaker includes seven funds with an AUM of $300m in the US and Southeast Asia which have all posted top-decile returns.
+ Read More
person
Ivan Soto-Wright
Soto-Wright is a leading financial technology entrepreneur and investor. Throughout his career, h
e has advocated for building systems and developing technologies that increase financial freedom.
+ Read More
person
Megan B. Miller, PhD
Megan B. Miller, PhD, is a socially minded neuroscientist with a passion for brain health advocac
y and strategic planning.
+ Read More
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Reimagining the Future of Employer-Sponsored Health Care to Drive Value: Survey Insights
Employer-sponsored health insurance (ESI) is the most common form of health insurance in the United
States, providing coverage for approximately 180 million people, or roughly half of the US population, and accounting for more than $1 trillion in health
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More